A PROSPECTIVE DATABASE OF INFANTS WITH CHOLESTASIS
胆汁淤积婴儿的前瞻性数据库
基本信息
- 批准号:7374374
- 负责人:
- 金额:$ 0.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-24 至 2007-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objectives of this research are to establish (1) a database containing clinical information and (2) a repository of blood and tissue samples from children with neonatal liver diseases such as biliary atresia and neonatal hepatitis to facilitate research in these important liver problems in children. This database and the specimens will be available for ancillary studies that will investigate the pathogenesis and natural history of biliary atresia and neonatal hepatitis or to evaluate patterns of cellular gene and protein expression in tissue specimens and plasma by viral, genomic and proteomic techniques. The study population will consist of infants, both male and female, with cholestasis who are less than or equal to 180 days old at the time of diagnosis at a Biliary Atresia Research Consortium (BARC) clinical site. In order to study the natural history, subjects will be followed until 10 years of age, liver transplantation or, for children without biliary atresia, until complete recovery off of all therapy. This study will: 1. collect detailed clinical and demographic information about each subject at enrollment and during follow up, 2. obtain and store blood and urine samples from the subject at diagnosis and during follow up, 3. obtain and store liver and biliary tissue and bile that are removed during diagnosis (i.e., biopsy) or at time of surgery or transplant and that are not needed for diagnostic purposes 4. collect demographic and medical history of parents at enrollment, and 5. obtain and store blood from the biological parents at enrollment. Samples of blood, urine, bile and tissue will be stored in repositories for future research. The data and biological specimens will be used for detailed study into the mechanisms and causes of liver problems in young children in order to try to better diagnose and manage these conditions. The subject will receive standard-of-care treatment and will not be restricted in type of treatment or from changes in treatment, such as newer treatments as they are developed. The subjects may not directly benefit from participation in this research, but in the future other children with similar problems may benefit from new information that may lead to better medical care.
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。本研究的主要目的是建立(1)包含临床信息的数据库和(2)来自患有新生儿肝脏疾病(如胆道闭锁和新生儿肝炎)的儿童的血液和组织样本的储存库,以促进对这些重要的儿童肝脏问题的研究。该数据库和标本将用于辅助研究,研究胆道闭锁和新生儿肝炎的发病机制和自然史,或通过病毒、基因组和蛋白质组学技术评价组织标本和血浆中细胞基因和蛋白质表达模式。研究人群将包括在胆道闭锁研究联盟(BARC)临床研究中心诊断时小于或等于180日龄的胆汁淤积婴儿(男性和女性)。为了研究自然史,将对受试者进行随访,直至10岁,接受肝移植,或者对于无胆道闭锁的儿童,直至所有治疗完全恢复。 本研究将:1.在招募时和随访期间收集关于每个受试者的详细临床和人口统计学信息,2.在诊断时和随访期间从受试者获得并储存血液和尿液样品,3.获得并储存在诊断期间取出的肝脏和胆管组织以及胆汁(即,活检)或在手术或移植时,并且不需要用于诊断目的4.收集入组时父母的人口统计学和病史,以及5.在入组时从亲生父母处获取并储存血液。 血液、尿液、胆汁和组织样本将储存在储存库中,以供未来研究。这些数据和生物标本将用于详细研究幼儿肝脏问题的机制和原因,以便更好地诊断和管理这些疾病。受试者将接受标准治疗,治疗类型或治疗变化(如开发的新治疗)不受限制。受试者可能不会直接受益于参与这项研究,但在未来,其他有类似问题的儿童可能会受益于新的信息,可能会导致更好的医疗保健。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD J. SOKOL其他文献
RONALD J. SOKOL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD J. SOKOL', 18)}}的其他基金
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
9926512 - 财政年份:2019
- 资助金额:
$ 0.49万 - 项目类别:
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
9926131 - 财政年份:2018
- 资助金额:
$ 0.49万 - 项目类别:
Colorado Clinical and Translational Sciences Institute: UL1 Diversity KL2 Supplement
科罗拉多临床和转化科学研究所:UL1 多样性 KL2 补充材料
- 批准号:
10288971 - 财政年份:2018
- 资助金额:
$ 0.49万 - 项目类别:
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
10402976 - 财政年份:2018
- 资助金额:
$ 0.49万 - 项目类别:
相似国自然基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
- 批准号:82371144
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
- 批准号:82371317
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
- 批准号:82371465
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
- 批准号:82370820
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
气体信号分子硫化氢对颈动脉窦压力反射感受器的调节作用及机制
- 批准号:81100181
- 批准年份:2011
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
精神分裂症特异微小RNA的筛选、鉴定及其靶向调控功能研究
- 批准号:81000583
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
人脐血间充质干细胞成骨潜能亚群的特异性分子标志
- 批准号:30800232
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
経胸壁心臓超音波のBlood Speckle Imagingを用いた大動脈弓部病変評価の研究
经胸心脏超声血斑成像评价主动脉弓病变的研究
- 批准号:
24K10591 - 财政年份:2024
- 资助金额:
$ 0.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
- 批准号:
23K24566 - 财政年份:2024
- 资助金额:
$ 0.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Open Access Block Award 2024 - NHS Blood and Transplant NHSBT School
2024 年开放获取块奖 - NHS 血液和移植 NHSBT 学校
- 批准号:
EP/Z532551/1 - 财政年份:2024
- 资助金额:
$ 0.49万 - 项目类别:
Research Grant
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 0.49万 - 项目类别:
Fellowship
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 0.49万 - 项目类别:
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 0.49万 - 项目类别:
An Integrated Model of Contextual Safety, Social Safety, and Social Vigilance as Psychosocial Contributors to Cardiovascular Disease
情境安全、社会安全和社会警惕作为心血管疾病社会心理因素的综合模型
- 批准号:
10749134 - 财政年份:2024
- 资助金额:
$ 0.49万 - 项目类别:
A methodology to connect functionalized gonadal constructs to a chick embryo through mechanically induced blood vessels from an egg
一种通过鸡蛋机械诱导血管将功能化性腺结构连接到鸡胚胎的方法
- 批准号:
24K15741 - 财政年份:2024
- 资助金额:
$ 0.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
STTR Phase I: A Completely Non-Toxic Blood Bag That Keeps Blood Healthier, Longer
STTR 第一阶段:完全无毒的血袋,使血液保持更健康、更长久
- 批准号:
2335363 - 财政年份:2024
- 资助金额:
$ 0.49万 - 项目类别:
Standard Grant
How blood vessel stiffness regulates their growth and maintenance
血管硬度如何调节其生长和维持
- 批准号:
DE240101055 - 财政年份:2024
- 资助金额:
$ 0.49万 - 项目类别:
Discovery Early Career Researcher Award














{{item.name}}会员




